The Connected Smart Drug Delivery Systems Market Size is valued at USD 4.2 Billion in 2024 and is predicted to reach USD 10.5 Billion by the year 2034 at a 10.0% CAGR during the forecast period for 2025-2034.
Connected Smart Drug Delivery Systems are the devices which perform multiple functions with the highest degree of smartness. Smart drug delivery devices help to reduce the dosage, frequency of the dosage and adverse effects of the drug. These devices are beneficial in the treatment of respiratory diseases, diabetes and other cardiovascular disorders. Connected smart drug delivery systems are more effective and can be self-managed. COVID-19 Pandemic is significantly augmenting the need for such smart (contactless) devices, and hence, in future, there will be a high requirement for such systems, which will ultimately result in Connected Smart Drug Delivery System’s market growth.
Connected smart drug delivery is an attractive industry option with multiple growth opportunities in research and development, technologies, applications, and formulations. Market analysis in terms of the product clearly suggests that the connected sensors segment dominated the market. And the COVID-19 Pandemic is also fueling new developments in the respiratory sector (inhalation devices). Also, recently a Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.
Spreading awareness regarding the benefits of connected smart systems over conventional systems is expected to enhance the product demand. Fast adoption of new technologies and smart devices, the invention of new products according to patients’ requirements, and the creation of smartphone applications and low-cost connectivity devices will also help grow this market.
The global connected smart drug delivery systems market is segmented on the basis of products, therapeutic area, end user and region. Products market is further categorized into connected inhalers, connected auto injectors, connected needle-free injectors, connected pen injectors, connected insulin pumps, connected wearable injectors/patch pumps, add-on sensors. Based on the different disorders market of therapeutic area can be subdivided into metabolic disorders, neurological disorders, respiratory disorders and others. On the basis of end user, market is sub-divided into hospitals, clinics, and homecare. Based on the region, the market of connected smart drug delivery systems has been segmented into north America, Asia-Pacific, Europe, And LAMEA. Among all, North America is expected to dominate the market during the analysis of forecast period.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 4.2 Billion |
| Revenue Forecast In 2034 | USD 10.5 Billion |
| Growth Rate CAGR | CAGR of 10.0% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Therapeutic Area, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; Japan; South Korea; South East Asia |
| Competitive Landscape | BIOCORP, Elcam Drug Delivery Devices (E3D), Novo Nordisk, Merck, Pneuma Respiratory, H&T Presspart, Nemera, Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Haselmeier Inc., Portal Instruments Inc, West Pharmaceutical Services Inc. , Emperra GmbH E-Health Technologies, Amiko Digital Health Limited, Cognita Labs,DIAMESCO CO., Ltd., Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical) , Enable Injections, Bigfoot Biomedical Inc., Medtronic Plc, Companion Medical , Sorrel Medical, Cohero Health, Inc., Propeller Health, Pendiq Intelligent Diabetes Care, Phillips-Medisize, Becton, Dickinson and Company (BD), Noble International Inc, etectRx, Aterica Inc., Findair Sp. z o. o., Recipharm AB, Aero Pump GmbH, Jiangsu Delfu medical device Co.,Ltd, and other prominent players. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Market Size (Value & Volume) & Forecasts and Trend Analyses, by Products
Market Size (Value & Volume) & Forecasts and Trend Analyses, by Therapeutic Area
Market Size (Value & Volume) & Forecasts and Trend Analyses, by based on End-User
Market Size (Value & Volume) & Forecasts and Trend Analyses, by based on region
Europe Connected Smart Drug Delivery Systems Market Revenue by Country,
North America Connected Smart Drug Delivery Systems Market Revenue by Country,
Asia Pacific Connected Smart Drug Delivery Systems Market Revenue by Country,
Latin America Connected Smart Drug Delivery Systems Market Revenue by Country,
Middle East & Africa Connected Smart Drug Delivery Systems Market Revenue by Country,
Competitive Landscape
Latest Strategic Developments
Companies Mentioned
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Connected Smart Drug Delivery Systems Market Snapshot
Chapter 4. Global Connected Smart Drug Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Connected Inhalers
5.2.2. Connected Autoinjectors
5.2.3. Connected Needle-Free Injectors
5.2.4. Connected Pen injectors
5.2.5. Connected Insulin Pumps
5.2.6. Connected Wearable Injectors/Patch Pumps
5.2.7. Add-On Sensors
Chapter 6. Connected Smart Drug Delivery Systems Market Segmentation 2: By Applications Estimates & Trend Analysis
6.1. By Therapeutic Area Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
6.2.1. Metabolic Disorders
6.2.2. Neurological Disorders
6.2.3. Respiratory Disorders
6.2.4. Others
Chapter 7. Connected Smart Drug Delivery Systems Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By Therapeutic Area Analysis & Market Share, 2024 & 2034
7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
7.2.1. Hospital
7.2.2. Clinics
7.2.3. Homecare
Chapter 8. Connected Smart Drug Delivery Systems Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Products, 2021-2034
8.1.2. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.1.3. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by End-Users, 2021-2034
8.1.4. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2021-2034
8.2.2. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2021-2034
8.2.3. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2021-2034
8.2.4. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2021-2034
8.3.2. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2021-2034
8.3.3. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2021-2034
8.3.4. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2021-2034
8.4.2. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2021-2034
8.4.3. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.4.4. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2021-2034
8.5.2. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2021-2034
8.5.3. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.5.4. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) by Country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. BIOCORP
9.2.2. Elcam Drug Delivery Devices (E3D)
9.2.3. Novo Nordisk
9.2.4. Merck
9.2.5. Pneuma Respiratory
9.2.6. H&T Presspart
9.2.7. Nemera
9.2.8. Ypsomed Holdings
9.2.9. Unolife Corporation
9.2.10. Quio Technologies
9.2.11. SHL Group
9.2.12. Haselmeier Inc.
9.2.13. Portal Instruments Inc
9.2.14. West Pharmaceutical Services Inc.
9.2.15. Emperra GmbH E-Health Technologies
9.2.16. Amiko Digital Health Limited
9.2.17. Cognita Labs
9.2.18. DIAMESCO CO., Ltd.?
9.2.19. Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical)
9.2.20. Enable Injections
9.2.21. Bigfoot Biomedical Inc.
9.2.22. Medtronic Plc
9.2.23. Companion Medical
9.2.25. Cohero Health, Inc.
9.2.26. Propeller Health
9.2.27. Pendiq Intelligent Diabetes Care
9.2.28. Phillips-Medisize
9.2.29. Becton, Dickinson and Company (BD)
9.2.30. Noble International Inc
9.2.31. etectRx
9.2.32. Aterica Inc.
9.2.33. Findair Sp. z o. o.
9.2.34. Recipharm AB
9.2.35. Aero Pump GmbH
9.2.36. Jiangsu Delfu medical device Co.,Ltd
8.3. List of Other Prominent Players